978
Index
Children
continued
gastrointestinal secretions, drugs
affecting, 899
hypoglycaemic agents, 574
hypothalamic and pituitary agents, 523
immune modulators, 260
laxatives and antidiarrhoeal agents, 917
lipid-lowering agents, 736
lower respiratory tract agents, 866
male reproductive system, drugs
affecting, 629
muscle relaxants, 386
neuromuscular junction (NMJ)
blocking agents, 435
opioids, 401
psychotherapeutic agents, 335
suicide, 328
thyroid and parathyroid agents, 554
upper respiratory tract agents, 844
urinary tract agents, 820
vaccines, 274, 275–277
parent education, 284–285
Chinese angelica, 963
Chloral hydrate, 313
Chlorambucil, 190, 195, 196, 198
Chloramphenicol, 87, 957
Chlorhexidine gluconate, 950
Chloride regulation, 798
Chloroquine, 166–169, 172
Chlorpheniramine, 852, 854
Chlorpromazine, 334–337, 341, 931,
932
Chlorpropamide, 587
Chlorthalidone, 675, 805, 807
Cholera, 281
Cholesterol, 729, 732–733
absorption inhibitors, 729, 738,
743–745
adverse effects, 744
care considerations, 744–745
contraindications and cautions, 743
drug–drug interactions, 744
pharmacokinetics, 743
therapeutic actions and indications,
743
combination therapy, 740, 746
Cholestyramine, 729, 735, 737, 739
Cholinergic agonists, 487–499
adults, 489
children, 489
direct-acting, 487, 488–491
adverse effects, 490
care considerations, 490–491
contradictions and cautions, 490
drug–drug interactions, 490
pharmacokinetics, 490
therapeutic actions and indications,
489–490
indirect-acting, 487, 491–498
adverse effects, 495
Alzheimer’s disease, agents for,
492–496
care considerations, 496
contraindications and cautions, 495
critical thinking scenario, 497–498
drug–drug interactions, 495
myasthenia gravis, agents for, 492
pharmacokinetics, 494–495
therapeutic actions and indications,
493–494
miosis, 487, 490
older adults, 489
Cholinergic crisis versus myasthenic
crisis, 493
Cholinergic receptors, 444, 451, 452
Cholinergic response, 450–452
Cholinesterase inhibitors, 437
Chondroitin, 963
Chong cao fungi, 964
Choriogonadotropin alpha, 526, 530,
617, 618
Chorionic gonadotropin, 526, 530, 617,
618
Chronic conditions, 44
Chronic obstructive pulmonary disease
(COPD), 834, 839, 865
Chrysotherapy, 240, 252
Chylomicron, 729, 731
Chyme, 888, 891
Ciclesonide, 875, 877, 953
Ciclopirox, 157, 951
Cidofovir, 132, 133
Cilia, 834, 835
Cilostazol, 755, 758
Cimetidine, 896, 897–899, 901, 903
Cinacalcet hydrochloride, 564
Cinchocaine, 425, 426
Cinchonism, 163
Ciprofloxacin, 90, 106, 107, 118, 820,
957
Ciprofloxacin/hydrocortisone, 951
Circle of Willis, 298
Circulation, 649–653
coronary circulation, 650–652
heart failure, 652–653
hypertension, 652
hypotension, 652
pulmonary, 649–650
renin–angiotensin–aldosterone system,
652, 653
systemic, 649, 650
systemic arterial pressure, 652
vasomotor tone, 652
venous pressure, 652–653
Cisatracurium, 434, 435, 437
Cisplatin, 195–197
Citalopram, 325, 326
Cladribine, 193, 200
Clarithromycin, 103, 122
Clary, 613
Clindamycin, 91, 104, 122, 123, 953
Clinical decision making, 42, 43–46
Clobetasol butyrate, 953
Clodronate, 566, 567
Clofaimine, 118, 119
Clofarabine, 200, 201
Clomiphene, 606, 617–619
Clomipramine, 317, 318, 319
Clonazepam, 354, 357, 359–360
Clonidine, 462, 463, 676
Clopidogrel, 755, 758
Clotrimazole, 157, 158, 951
Clotting, 751–754
anticlotting, 754
clot resolution, 754
factors, 750, 751
studies, 760, 763
vitamin K and, 763
Clozapine, 334, 336, 338, 341
Coagulation, drugs affecting, 750–771
adults, 752
blood coagulation, 751–754
children, 752
clotting.
See
Clotting
disorders affecting blood coagulation,
754–755
haemorrhagic disorders, 755
thromboembolic disorders, 754–755
drugs affecting clot formation and
resolution, 755–767
anticoagulant adjunctive therapy, 766
anticoagulants.
See
Anticoagulants
antiplatelet agents.
See
Antiplatelet
agents
low-molecular-weight heparins, 751,
757, 766
thrombolytic agents.
See
Thrombolytic agents
drugs used to control bleeding, 767–771
antihaemophilic agents.
See
Antihaemophilic agents
haemostatic agents.
See
Haemostatic
agents
older adults, 752
Coagulation factors, 767–769
Cocaine, 67
Codeine, 401, 402, 844, 845
Colaspase, 200, 201, 203
Colestipol, 735, 737
Coleus forskohlii
, 964
Combination therapy, 86, 93
Co-methylcobalamin, 787
Comfrey, 964
Common cold, 834, 837–838
Competitive antagonists, 15, 17
Complement proteins, 228, 234
Complementary therapies.
See
Alternative
and complementary therapies
Conductivity, 642, 645, 697
Constipation, 916, 917
opioid-induced, 405
Consumer awareness, 61–62
Internet, 61–62
media influence, 61
Contraceptives, 611–612, 616–617
Contraindications, reviewing, 32
Convulsions, 352, 353
COPD (chronic obstructive pulmonary
disease), 834, 839
Coreceptor antagonist, 126
Coriander, 471, 582, 964
Coronary artery disease (CAD), 713,
714–715, 730–731
acute myocardial infarction, 715
angina, 715
risk factors, 729–732
treatment, 731
Coronary circulation, 650–652
